NOS2 and nasopharyngeal carcinoma: After confirmation that M1 macrophages are present in chronic stages of SCI, their functional activity and spatial distribution were evaluated by measuring the immunodensity of iNOS, a marker enzyme for M1 macrophages (control, n = 6; NPC, n = 7).